{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:50:50Z","timestamp":1758970250981},"reference-count":36,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.2169\/internalmedicine.5045-20","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T22:07:20Z","timestamp":1604182040000},"page":"2719-2724","source":"Crossref","is-referenced-by-count":4,"title":["Bardet-Biedl Syndrome Caused by Skipping of <i>SCLT1<\/i> Complicated by Microvesicular Steatohepatitis"],"prefix":"10.2169","volume":"59","author":[{"given":"Kentaro","family":"Horiuchi","sequence":"first","affiliation":[{"name":"Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Kogiso","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaomi","family":"Sagawa","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taito","family":"Ito","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Taniai","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoshi","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Morisada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Seibu Railway Company Health Support Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Tokushige","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Bardet G. Sur un syndrome d'ob\u00e9sit\u00e9 cong\u00e9nitale avec polydactylie et r\u00e9unite pigmentaire (contribution \u00e1 l'etude des formes cliniques de l'ob\u00e9site hypophysaire). Th\u00e9se de Paris 170: 107, 1920 (in French)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Green JS, Parfrey PS, Harnett JD, et al. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 321: 1002-1009, 1989.","DOI":"10.1056\/NEJM198910123211503"},{"key":"3","unstructured":"3. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet 36: 437-446, 1999."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pagon RA, Haas JE, Bunt AH, Rodaway KA. Hepatic involvement in the Bardet-Biedl syndrome. Am J Med Genet 13: 373-381, 1982.","DOI":"10.1002\/ajmg.1320130405"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakamura F, Sasaki H, Kajihara H, Yamanoue M. Laurence-Moon-Biedl syndrome accompanied by congenital hepatic fibrosis. J Gastroenterol Hepatol 5: 206-210, 1990.","DOI":"10.1111\/j.1440-1746.1990.tb01826.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Forsythe E, Kenny J, Bacchelli C, Beales PL. Managing Bardet-Biedl syndrome-now and in the future. Front Pediatr 6: 23, 2018.","DOI":"10.3389\/fped.2018.00023"},{"key":"7","unstructured":"7. Tobin JL, Beales PL. Bardet-Biedl syndrome: beyond the cilium. Pediatr Nephrol 22: 926-936, 2007."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Klein D, Ammann F. The syndrome of Laurence-Moon-Bardet-Biedl and allied diseases in Switzerland. Clinical, genetic and epidemiological studies. J Neurol Sci 9: 479-513, 1969.","DOI":"10.1016\/0022-510X(69)90091-4"},{"key":"9","unstructured":"9. Beales PL, Warner AM, Hitman GA, Thakker R, Flinter FA. Bardet-Biedl syndrome: a molecular and phenotypic study of 18 families. J Med Genet 34: 92-98, 1997."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hirano M, Satake W, Ihara K, et al. The first nationwide survey and genetic analyses of Bardet-Biedl syndrome in Japan. PLoS One 10: e0136317, 2015.","DOI":"10.1371\/journal.pone.0136317"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Forsythe E, Beales PL. Bardet-Biedl syndrome. Eur J Hum Genet 21: 8-13, 2013.","DOI":"10.1038\/ejhg.2012.115"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Morisada N, Hamada R, Miura K, et al. Bardet-Biedl syndrome in two unrelated patients with identical compound heterozygous SCLT1 mutations. CEN Case Rep 9: 260-265, 2020.","DOI":"10.1007\/s13730-020-00472-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maria M, Lamers IJ, Schmidts M, et al. Genetic and clinical characterization of Pakistani families with Bardet-Biedl syndrome extends the genetic and phenotypic spectrum. Sci Rep 6: 34764, 2016.","DOI":"10.1038\/srep34764"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tanos BE, Yang HJ, Soni R, et al. Centriole distal appendages promote membrane docking, leading to cilia initiation. Genes Dev 27: 163-168, 2013.","DOI":"10.1101\/gad.207043.112"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Li J, Lu D, Liu H, et al. Sclt1 deficiency causes cystic kidney by activating ERK and STAT3 signaling. Hum Mol Genet 26: 2949-2960, 2017.","DOI":"10.1093\/hmg\/ddx183"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Katagiri S, Hayashi T, Yoshitake K, et al. Compound heterozygous splice site variants in the SCLT1 gene highlight an additional candidate locus for Senior-L\u00f8ken syndrome. Sci Rep 8: 16733, 2018.","DOI":"10.1038\/s41598-018-35152-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Oh EC, Vasanth S, Katsanis N. Metabolic regulation and energy homeostasis through the primary Cilium. Cell Metab 21: 21-31, 2015.","DOI":"10.1016\/j.cmet.2014.11.019"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mak HY, Nelson LS, Basson M, Johnson CD, Ruvkun G. Polygenic control of Caenorhabditis elegans fat storage. Nat Genet 38: 363-368, 2006.","DOI":"10.1038\/ng1739"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee BH, Liu J, Wong D, Srinivasan S, Ashrafi K. Hyperactive neuroendocrine secretion causes size, feeding, and metabolic defects of C. elegans Bardet-Biedl syndrome mutants. PLoS Biol 9: e1001219, 2011.","DOI":"10.1371\/journal.pbio.1001219"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Eichers ER, Abd-El-Barr MM, Paylor R, et al. Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity. Hum Genet 120: 211-226, 2006.","DOI":"10.1007\/s00439-006-0197-y"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rahmouni K, Fath MA, Seo S, et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest 118: 1458-1467, 2008.","DOI":"10.1172\/JCI32357"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Feuillan PP, Ng D, Han JC, et al. Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance. J Clin Endocrinol Metab 96: E528-E535, 2011.","DOI":"10.1210\/jc.2010-2290"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12: 1106-1110, 1990.","DOI":"10.1002\/hep.1840120505"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Singh Y, Singh M, Saxena SR, Prakash S, Joshi A. Bardet-Biedl syndrome with nonalcoholic steatohepatitis, hypertension, and hypothyroidism. Chrismed Journal of Health and Research 3: 128-130, 2016.","DOI":"10.4103\/2348-3334.177635"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tandra S, Yeh MM, Brunt EM, et al. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol 55: 654-659, 2011.","DOI":"10.1016\/j.jhep.2010.11.021"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 26 (Suppl 2): 43-53, 1997.","DOI":"10.1016\/S0168-8278(97)80496-5"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Chitturi S, Farrell G, Frost L, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 36: 403-409, 2002.","DOI":"10.1053\/jhep.2002.34738"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52: 1836-1846, 2010.","DOI":"10.1002\/hep.24001"},{"key":"29","unstructured":"29. Cai C, Song X, Chen Y, Chen X, Yu C. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Hepatol Int 14: 115-126, 2020."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Grace C, Beales P, Summerbell C, et al. Energy metabolism in Bardet-Biedl syndrome. Int J Obes Relat Metab Disord 27: 1319-1324, 2003.","DOI":"10.1038\/sj.ijo.0802420"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Guo DF, Rahmouni K. Molecular basis of the obesity associated with Bardet-Biedl syndrome. Trends Endocrinol Metab 22: 286-293, 2011.","DOI":"10.1016\/j.tem.2011.02.009"},{"key":"32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/377530a0","volume":"377","author":"TW Stephens","year":"1995","unstructured":"32. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532, 1995.","journal-title":"?Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Zigman JM, Elmquist JK. Minireview: From anorexia to obesity-the yin and yang of body weight control. Endocrinology 144: 3749-3756, 2003.","DOI":"10.1210\/en.2003-0241"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet 18: 1323-1331, 2009.","DOI":"10.1093\/hmg\/ddp031"},{"key":"35","unstructured":"35. B\u00fcscher AK, Cetiner M, B\u00fcscher R, Wingen AM, Hauffa BP, Hoyer PF. Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones. Pediatr Nephrol 27: 2065-2071, 2012."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Boscolo M, F\u00e9ry F, Cnop M. Beneficial outcomes of sleeve gastrectomy in a morbidly obese patient with Bardet-Biedl syndrome. J Endocr Soc 1: 317-322, 2017.","DOI":"10.1210\/js.2017-00071"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/21\/59_5045-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T03:49:27Z","timestamp":1604720967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/21\/59_5045-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":36,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5045-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}